Oklahoma City has been a force of nature all season long, and as the season comes to a close, this team appears to be fully hitting its stride. At points across ...

Whitehawk Therapeutics, Inc. , an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments, today announced the ...

Investing.com — 白鹰制药公司(Whitehawk Therapeutics, Inc.)(NASDAQ: WHWK)，一家临床前阶段的肿瘤治疗公司，目前市值为4800万美元，今日宣布完成了将Aadi子公司(Aadi Subsidiary, Inc.)战略性出售给科研制药(Kaken Pharmaceuticals)的交易。此次出售包括Aadi Bioscience名称、商标和FYA ...

New name reflects focus on accelerating portfolio of advanced ADC therapies with speed, agility and precision Upon closing of strategic transactions, cash expected ...

Whitehawk Therapeutics (Nasdaq: WHWK), formerly Aadi Bioscience, has officially rebranded to reflect its transformation into ...

New option listings for March 19th include Colombier Acquisition Corp II (CLBR), Danimer Scientific, Inc. (DNMRQ), Kalaris Therapeutic Inc.